Market Snapshot
S&P Futures
4,132.75
Dow Futures
32,794
Nasdaq Futures
13,103.75
Amryt Pharma plc (AMYT) stock declined over - intraday to trade at $7.87 a share on NASDAQ. The stock opened with a gain of 3.15% at $7.87 and touched an intraday high of $8.17, rising 0.00% against the last close of $7.87. The stock went to a low of $7.807 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-08 | $7.87 | $8.17 | $7.807 | $7.87 | 57,285 |
2022-08-05 | $7.63 | $8.056 | $7.63 | $7.87 | 26,500 |
2022-08-04 | $7.11 | $7.86 | $7.11 | $7.77 | 56,700 |
2022-08-03 | $7.419 | $7.459 | $7.36 | $7.4 | 15,000 |
2022-08-02 | $7.43 | $7.43 | $7.15 | $7.41 | 51,900 |
2022-08-01 | $7.34 | $7.59 | $7 | $7.355 | 59,000 |
2022-07-29 | $7.41 | $7.52 | $7.24 | $7.26 | 45,000 |
2022-07-28 | $7.485 | $7.575 | $7.39 | $7.49 | 28,200 |
2022-07-27 | $7.35 | $7.535 | $7.35 | $7.47 | 16,600 |
2022-07-26 | $7.35 | $7.575 | $7.32 | $7.41 | 40,500 |
Employees-
Beta-
Sales or Revenue233.24 Million
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the rare cholesterol disorder. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.
Amryt Pharma plc (NASDAQ: AMYT) stock price is $7.87 as of the last check on Monday, August 8. During the trading session, AMYT stock reached the peak price of $8.17 while $7.807 was the lowest point it dropped to.
The NASDAQ listed AMYT is part of Pharmaceuticals industry that operates in the broader Health Care sector. Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the rare cholesterol disorder.
Mr. Stephen Joyce
VP of Global Marketing
Dr. Mark Sumeray FRCS, M.D., M.S.
Chief Medical Officer
Dr. Joseph A. Wiley
CEO & Director
Mr. Rory P. Nealon
CFO, COO & Company Sec.
AMYT stock traded closed the last session at $7.87, which is $0 or 0% lower than its previous close of $7.87. AMYT's current trading price is 40.29% lower than its 52-week high of $12.45 where as its distance from 52-week low of 5.61% is -36.79%.
Number of AMYT employees currently stands at -. AMYT operates from 45 Mespil Road, Dublin 4, Ireland.
Official Webiste of $AMYT is: https://www.amrytpharma.com
AMYT could be contacted at AMYT operates from 45 Mespil Road, Dublin 4, Ireland, or at phone #353 1 518 0200 and can also be accessed through its website.
AMYT stock volume for the day was 57,285 shares while in the previous session number of AMYT shares traded was 57,285 . The average number of AMYT shares traded daily for last 3 months was 78 Thousands.
The percentage change in AMYT stock occurred in the recent session was 0% while the dollar amount for the price change in AMYT stock was $0.
In the recent session, the day high for AMYT stock was $8.17 while the low for AMYT stock touched on the day was $7.807.
The market value of AMYT currently stands at 620.79 Million with its latest stock price at $7.87 and 64.16 Million of its shares outstanding.